Search

Your search keyword '"Lanke, Kjerstin"' showing total 481 results

Search Constraints

Start Over You searched for: Author "Lanke, Kjerstin" Remove constraint Author: "Lanke, Kjerstin"
481 results on '"Lanke, Kjerstin"'

Search Results

1. Plasmodium falciparum gametocyte carriage in longitudinally monitored incident infections is associated with duration of infection and human host factors

2. Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trial

3. Plasmodium falciparum gametocyte production correlates with genetic markers of parasite replication but is not influenced by experimental exposure to mosquito biting

4. Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali

5. Dynamics of asymptomatic Plasmodium falciparum and Plasmodium vivax infections and their infectiousness to mosquitoes in a low transmission setting of Ethiopia: a longitudinal observational study

6. SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients

8. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.

9. Quantification of sporozoite expelling by Anopheles mosquitoes infected with laboratory and naturally circulating P. falciparum gametocytes

10. Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study

11. Anopheles stephensi Mosquitoes as Vectors of Plasmodium vivax and P. falciparum, Horn of Africa, 2019

12. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2 single-blind randomised clinical trial in Ouelessebougou, Mali

14. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.

16. Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections

17. SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

18. A transmission bottleneck for malaria? Quantification of sporozoite expelling from laboratory and natural P. falciparum infections

19. The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia

20. Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding

21. A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance

23. Comparison of infectivity of Plasmodium vivax to wild-caught and laboratory-adapted (colonized) Anopheles arabiensis mosquitoes in Ethiopia

25. Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria

28. Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of Plasmodium vivax gametocytes to Anopheles arabiensis mosquitoes

29. Active Screening and Treatment Significantly Reduces the Infectious Reservoir of Malaria in Burkina Faso: Results from a Randomised Trial

31. Additional file 1 of Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes

32. Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial

33. Plasmodium falciparum gametocyte production in longitudinally monitored incident infections is associated with duration of infection and human host factors

36. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial

38. Persistence of P. falciparum HRP-2 antigenaemia post treatment is not associated with gametocytes

39. Asymptomatic School-Aged Children Are Important Drivers of Malaria Transmission in a High Endemicity Setting in Uganda

40. Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial

41. A Cohort Study on the Duration of Plasmodium falciparum Infections During the Dry Season in The Gambia

42. Human antibodies against noncircumsporozoite proteins block Plasmodium falciparum parasite development in hepatocytes

44. Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial

45. A cohort study on the duration of Plasmodium falciparum infections during the dry season in The Gambia

47. SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

48. Persistent malaria transmission from asymptomatic children despite highly effective malaria control in eastern Uganda

49. G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials

50. Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms

Catalog

Books, media, physical & digital resources